Rosenverse

Log in or create a free Rosenverse account to watch this video.

Log in Create free account

100s of community videos are available to free members. Conference talks are generally available to Gold members.

Digital Medicine Design

Thursday, September 26, 2019 • Enterprise Community
Share the love for this talk
Digital Medicine Design
Speakers: Daniel J. Rosenberg
Link:

Summary

Can a software only mobile solution outperform a pharmaceutical drug in clinical trials? Is it possible to create an app only available via a doctor’s prescription? The answer to both questions is a responding YES! In this webinar, Dan walked through several medical product case studies he has consulted on. The first is the WellDoc BlueStar solution for type 2 diabetes patients. BlueStar was the first instance of Digital Medicine invented. BlueStar received both an FDA class 2 certification and a prescription drug code for insurance reimbursement. Legally speaking this 100% software only solution is a medication. In clinical trials it has proven to reduce high-risk type 2 patients A1C levels by more than 1.8 points, outperforming many commonly prescribed medications. The second case study is Bigfoot Biomedical’s artificial pancreas for type 1 diabetics. It has completed its first clinical trial rounds but is not yet in the market. This solution uses an amazing combination of AI, big data and IoT embedded in the human body to automate insulin delivery 24/7. The primary UX resides on the patients’ phone. Interfaces for doctors and insurance companies will complete the end to end system experience including an innovative direct to patients supply chain. In addition to these amazing case studies this webinar described the similarities between digital medicine design and Enterprise UX. You will be surprised to see how much they have in common as well as what else you need to know to enter this cutting-edge UX domain.

Key Insights

  • Digital medicine apps like BlueStar are prescription-only and undergo FDA clearance, making them legally a pharmaceutical class.

  • Only a tiny fraction (about 0.01%) of diabetes apps are FDA-cleared to ensure clinical effectiveness.

  • BlueStar outperforms metformin in lowering A1C by about 2 points through data science and gamification.

  • Bigfoot’s artificial pancreas integrates continuous glucose monitoring with an insulin pump controlled by smartphone, allowing personalized insulin dosing.

  • Medical UX design involves multi-actor systems including patients, caregivers, doctors, payers, pharmacies, and must consider HIPAA regulations.

  • The onboarding and provisioning processes in medical software are far more complex than in enterprise software due to prescriptions, insurance, and regulatory needs.

  • Safety is always the top design priority in digital medicine, followed by privacy and usability.

  • FDA agile process is highly regulated and closer to waterfall with strong documentation and traceability requirements, especially for higher-risk devices.

  • Contextual data like elevation, temperature, and activity levels can personalize insulin dosing algorithms in digital medicine products.

  • User retention issues in medical apps can sometimes mean success, as patients stop using the app after achieving stable health control.

Notable Quotes

"Digital medicine apps are legally considered a pharmaceutical, available by prescription only."

"About 200,000 digital health products exist, but only 1% of 1% have FDA clearance for accuracy."

"BlueStar lowered users' A1C by 2 points, outperforming the most common drug metformin which averages 1.5."

"If the phone dies, Bigfoot’s insulin pump continues working independently, but without new data input."

"You have to keep the injection sites moving because of scar tissue, adding to the body hacking complexity."

"Safety is your number one concern, privacy is your number two, and usability is number three."

"A lot of these companies have founders or investors who are themselves doctors or diabetic patients."

"Design history files must document every design decision for FDA audits—it's far more rigorous than typical usability tests."

"The FDA-approved agile process is more like a controlled waterfall with strict traceability, especially for Class 3 devices."

"If patients stop using the app because they’ve got their health under control, that’s like a dating app success — they got married, not that the app failed."

Ask the Rosenbot
Kara Kane
Communities of Practice for Civic Design
2022 • Civic Design Community
Lija Hogan
Doing more with more: Lessons from the Front Lines of Democratization
2022 • Advancing Research 2022
Gold
Russ Unger
Onboarding: The Ecosystem, not the Afterthought
2017 • DesignOps Summit 2017
Gold
Robin Beers
Navigating organizational systems: Rethinking researcher’s role in driving change
2025 • Advancing Research 2025
Gold
Carol Smith
Operationalizing Responsible, Human-Centered AI
2023 • Enterprise UX 2023
Gold
Dianne Que
Real Talk: Proving Value through a Scrappy Playbook
2019 • DesignOps Summit 2019
Gold
Saara Kamppari-Miller
Cartography for Design Communities
2025 • DesignOps Summit 2025
Gold
Andy Polaine
What is the role of service design in product-led organizations?
2024 • Advancing Service Design 2024
Gold
Samuel Proulx
Inclusive Research: Debunking Myths and Getting Started
2025 • Advancing Research 2025
Gold
Tatyana Mamut
Opening Keynote: Breaking Conway's Law--or How to Work Differently and Not Ship Your Org Chart
2019 • Enterprise Experience 2019
Gold
Kristin Skinner
Group Activity: A Deep Dive Into Value and Outcomes
2019 • DesignOps Summit 2019
Gold
Sam Proulx
To Boldly Go: The New Frontiers of Accessibility
2022 • Design at Scale 2022
Gold
Jemma Ahmed
Theme Panel
2025 • Advancing Research 2025
Gold
Ruzanna Rozman
Getting in Flow with Your Team
2024 • DesignOps Summit 2020
Gold
Sahibzada Mayed
Cultivating Design Ecologies of Care, Community, and Collaboration
2023 • DesignOps Summit 2023
Gold
Jon White
Unsticking Research for Better Information Flow
2026 • Advancing Research 2026
Gold

More Videos

Greg Petroff

"If we deeply understand outcomes and advocate for impact, we’ll be the ones making real change happen in the enterprise."

Greg Petroff

Software as Material—A Redux

June 6, 2023

Brendan Jarvis

"Who do you see? Who do you not see? Why do you not see them?"

Brendan Jarvis

Framing Tomorrow by Questioning Today

June 8, 2022

Prerna Makanawala

"A service leadership approach means you’re here to help and orchestrate, not to command and control."

Prerna Makanawala

Achieving Balanced Design Consistency

June 9, 2021

Tricia Wang

"Thick data is the opposite of big data and essential for rescuing lost context."

Tricia Wang

From Users to Shapers of AI: The Future of Research

March 25, 2024

Cheryl Platz

"Mastery is a core human motivator; people want to understand and feel competent in what they do."

Cheryl Platz

Embrace Your Fun Factor: Game Development Best Practices for Product Design

January 9, 2026

Ariel Kennan

"The roles of who is designing continue to shift—community designing for community, designing with community, and community members becoming consultants."

Ariel Kennan

Theme Two Intro

November 17, 2022

Tricia Wang

"Designers are the most insecure function in many companies because their role—to represent people's needs—is both critical and ambiguous."

Tricia Wang

The most popular design thinking strategy is BS

January 27, 2022

Kristin Wisnewski

"The state of IT is a daily reflection of what the company thinks and feels about its employees."

Kristin Wisnewski

Measuring What Matters

October 23, 2019

Scott Jensen

"I wish I knew it was okay to invest in relationships; that’s how incremental change happens."

Scott Jensen Sarah Delaney Carmen Liu

Short Take #2: UX/Product Lessons from Your Industry Peers

December 6, 2022